LONA (LeonaBio, Inc.) Stock Financials & Earnings | Market Cap Arena

LONALeonaBio, Inc.

Mkt Cap$26M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$38M

EPS (TTM)-$9.66

Free Cash Flow (TTM)-$52M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 12

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$33M
Q1 23	$0	$0	-$30M
Q2 23	$0	$0	-$32M
Q3 23	$0	$0	-$35M
Q4 23	$0	$0	-$29M
Q1 24	$0	-$242K	-$28M
Q2 24	$0	-$242K	-$28M
Q3 24	$0	$0	-$30M
Q4 24	$0	$0	-$16M
Q1 25	$0	-$243K	-$10M
Q2 25	$0	-$200K	-$7M
Q3 25	$0	-$243K	-$7M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$16M	-$16M
Q1 23	-$26M	-$26M
Q2 23	-$24M	-$24M
Q3 23	-$24M	-$24M
Q4 23	-$26M	-$26M
Q1 24	-$26M	-$26M
Q2 24	-$22M	-$22M
Q3 24	-$23M	-$23M
Q4 24	-$26M	-$26M
Q1 25	-$15M	-$15M
Q2 25	-$7M	-$7M
Q3 25	-$5M	-$5M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$1K
Q1 23	$241K
Q2 23	$33K
Q3 23	$30K
Q4 23	$0
Q1 24	$5K
Q2 24	$28K
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+75.3%
Q1 23	—	+27.3%
Q2 23	—	+34.2%
Q3 23	—	+45.2%
Q4 23	—	-11.9%
Q1 24	—	-7.0%
Q2 24	—	-11.4%
Q3 24	—	-15.5%
Q4 24	—	-46.4%
Q1 25	—	-65.6%
Q2 25	—	-74.0%
Q3 25	—	-76.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	—
Q1 23	$0	—
Q2 23	$3M	—
Q3 23	$2M	—
Q4 23	$2M	—
Q1 24	$3M	—
Q2 24	$3M	—
Q3 24	$3M	—
Q4 24	$2M	—
Q1 25	$2M	—
Q2 25	$2M	—
Q3 25	$1M	—

OpEx Breakdown

Quarter	R&D	G&A
Q4 22	$15M	$8M
Q1 23	$21M	$8M
Q2 23	$22M	$10M
Q3 23	$27M	$8M
Q4 23	$24M	$7M
Q1 24	$21M	$6M
Q2 24	$22M	$6M
Q3 24	$18M	$8M
Q4 24	$9M	$6M
Q1 25	$4M	$5M
Q2 25	$4M	$4M
Q3 25	$3M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$96M	$104M	$200M
Q1 23	$105M	$81M	$186M
Q2 23	$114M	$72M	$186M
Q3 23	$110M	$63M	$173M
Q4 23	$91M	$57M	$147M
Q1 24	$78M	$44M	$122M
Q2 24	$74M	$18M	$92M
Q3 24	$69M	$0	$69M
Q4 24	$48M	$3M	$51M
Q1 25	$26M	$10M	$37M
Q2 25	$20M	$10M	$30M
Q3 25	$21M	$4M	$25M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	4M	+0.0%
Q1 23	4M	+0.3%
Q2 23	4M	+0.2%
Q3 23	4M	+0.1%
Q4 23	4M	+0.1%
Q1 24	4M	+0.6%
Q2 24	4M	+0.2%
Q3 24	4M	+0.4%
Q4 24	4M	-0.1%
Q1 25	4M	+1.5%
Q2 25	4M	+0.1%
Q3 25	4M	+0.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$0	22
FY 21	$0	35
FY 22	$0	64
FY 23	$0	67
FY 24	$0	26

LONA (LeonaBio, Inc.) Stock Financials & Earnings | Market Cap Arena